Registry of Device Implantation

Condition(s) studied

Investigational drug(s) / intervention(s)

implantation of cardiac devices: implantation of cardiac devices

Study summary

The implantable device therapy for cardiac arrhythmias has been an established therapy, and one of the common standard procedures in cardiac clinical practice.

Pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy have been developed since 1960s, and the technologies in this field are still progressively developing. Not only these "traditional" implantable devices, there are multiple new devices for cardiac diseases, such as implantable loop recorder, vagal nerve stimulator and barostimulator.

The aim of this registry is to demonstrate the efficacy and the safety of standard device implantation procedures and to evaluate/ identify specific factors, including clinical characteristics, laboratory data and procedural data, which predict the prognosis/complication of the patients. These identification will result in further improvement of patients' care.

Eligibility

Primary outcome measure(s)

• device related adverse events — during index hospital admission
  Adverse events as occurrence of perioperative and postoperative complication related to the device implantation during the index hospital admission
• Adverse Events — during index hospital admission
  Adverse Events as occurrence of atrial fibrillation, occurrence of syncope, occurrence of sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or appropriate ICD therapy including antitachycardia pacing (ATP) and shock, occurrence of inadequate ICD therapy including ATP and shock in ICD/CRT-D patients, hospital admission due to cardiac disease and therapy, cardiac death

Trial sites (1)

More Klinik für Kardiologie, Pneumologie und Angiologie trials in Germany

Other trials for the same condition